Prasad Devarajan, MD, FAAP, FASN
- Director, Division of Nephrology and Hypertension
- Louise M. Williams Endowed Chair
- Medical Director, Stone Center
- Director, Nephrology Clinical and Biomarker Laboratory
- Professor, UC Department of Pediatrics
- prasad.devarajan@cchmc.org
- Board Certified
About
Biography
As a pediatric nephrologist, I treat children and adolescents who have kidney stones, acute kidney injuries and chronic kidney diseases. I believe that patients always come first, and that patient care is job one.
Although we are a group practice, each one of us is proud and privileged to continuously follow each patient and their family. We provide personalized care to every child. Children can get sick quickly, but with good care they typically recover fast and completely. It’s very rewarding to see a sick child transformed into a healthier kid as a result of our good care in partnership with their family.
Children are not consumers or customers — their health is our responsibility. We are more than providers. We are privileged to have the honor and responsibility for their care, to cure their diseases and to help them maintain good health. We also continuously pursue clinical excellence with our innovative research.
I have authored about 300 peer-reviewed publications and 70 book chapters, and I have delivered more than 200 invited lectures internationally. My research activities have been continuously funded by the National Institutes of Health (NIH) and other agencies for more than 30 years. This work spans the spectrum of highly collaborative basic, translational and clinical inquiries, all focused on improving child health. I have consistently been listed in Thomson Reuters "World's Most Influential Scientific Minds" in recognition of ranking among the top 1% of researchers for most cited publications in the entire field of medicine.
In my research, we are actively investigating mechanisms that cause the kidney to fail acutely and chronically. The results of these investigations are providing us with novel biomarkers to predict kidney disease, and also with new pathways we can target with innovative therapies. We are at the forefront nationally and internationally in the care of children with kidney disease.
In my free time, I practice meditation and deep reflection. I also love taking long walks with my dog.
Premedical Studies: Bombay University, India, 1979.
MD: Bombay University, India, 1985.
Services and Specialties
Nephrology and Hypertension, Kidney Transplant, Kidney Disease, End-Stage Renal Disease, Lupus, Nephrology - Acute Care, Kidney Stones
Research Areas
Nephrology and Hypertension, Developmental Biology, Fibrosis
Additional Languages
HindiLocations (2)
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in Children. Kidney 360. 2024; 5:821-833.
Evaluation of diagnostic accuracy of urine neutrophil gelatinase-associated lipocalin in patients with symptoms of urinary tract infections: a meta-analysis. Frontiers in Pediatrics. 2024; 12:1368583.
A proposed framework for advancing acute kidney injury risk stratification and diagnosis in children: a report from the 26th Acute Disease Quality Initiative (ADQI) conference. Pediatric Nephrology. 2024; 39:929-939.
Advances in pediatric acute kidney injury pathobiology: a report from the 26th Acute Disease Quality Initiative (ADQI) conference. Pediatric Nephrology. 2024; 39:941-953.
Pediatric AKI in the real world: changing outcomes through education and advocacy-a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. Pediatric Nephrology. 2024; 39:1005-1014.
Advances in pediatric acute kidney injury pharmacology and nutrition: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. Pediatric Nephrology. 2024; 39:981-992.
Epidemiology of acute kidney injury in children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. Pediatric Nephrology. 2024; 39:919-928.
Fluid assessment, fluid balance, and fluid overload in sick children: a report from the Pediatric Acute Disease Quality Initiative (ADQI) conference. Pediatric Nephrology. 2024; 39:955-979.
Programs and processes for advancing pediatric acute kidney support therapy in hospitalized and critically ill children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. Pediatric Nephrology. 2024; 39:993-1004.
Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin. Pediatric Nephrology. 2024; 39:269-282.
From the Blog
NIAMS-Funded Clinical Trial Featured on Lupus Foundation Podcast
Prasad Devarajan, MD, Hermine I. Brunner, MD, MSc, MBA2/9/2024
Location, Location, Location: A New Paradigm for Kidney Fibrosis
Prasad Devarajan, MD1/8/2024
First Acute Kidney Injury Diagnostic Test Wins FDA Clearance
Prasad Devarajan, MD, Stuart L. Goldstein, MD, FAAP, FNKF12/7/2023
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey